Example: Heart Attack

Search clinical trials for: Ibudilast

Total 19 results

    • NCT02714036
      Completed
      A Biomarker Study to Evaluate MN-166 (Ibudilast) in Subjects With Amyotrophic Literal Sclerosis (ALS)
      Conditions: Amyotrophic Lateral Sclerosis
    • NCT04057898
      Recruiting
      Evaluation of MN-166 (Ibudilast) for 12 Months Followed by an Open-label Extension for 6 Months in Patients With ALS
      Conditions: Amyotrophic Lateral Sclerosis
    • NCT02025998
      Completed
      Development of Ibudilast for Alcohol Use Disorder
      Conditions: Alcohol Use Disorders
    • NCT04429555
      Recruiting
      Efficacy, Safety, Tolerability, and Biomarkers of MN-166 (Ibudilast) in Patients Hospitalized With COVID-19 and at Risk for ARDS
      Conditions: Pneumonia, Viral
    • NCT03594435
      Recruiting
      Ibudilast for the Treatment of Alcohol Use Disorder
      Conditions: Alcohol Use Disorder
    • NCT03782415
      Recruiting
      Study to Evaluate Ibudilast and TMZ Combo Treatment in Newly Diagnosed and Recurrent Glioblastoma
      Conditions: Glioblastoma; Recurrent Glioblastoma; GBM; Recurrent GBM
    • NCT01982942
      Completed
      Safety, Tolerability and Activity Study of Ibudilast in Subjects With Progressive Multiple Sclerosis
      Conditions: Multiple Sclerosis, Primary Progressive; Multiple Sclerosis, Secondary Progressive
    • NCT01389193
      Completed
      Ibudilast in the Treatment of Patients With Chronic Migraine.
      Conditions: Migraine Headache
    • NCT03341078
      Recruiting
      Pilot Study of the Effect of Ibudilast on Neuroinflammation in Methamphetamine Users
      Conditions: Methamphetamine-dependence
    • NCT04054206
      Completed
      Relative Bioavailability of MN-166 (Ibudilast) in Extended Release Tablet vs. Intermediate-release Capsule in Healthy Volunteers
      Conditions: Healthy Volunteers
    • NCT01317992
      Unknown status
      Ibudilast in the Treatment of Medication Overuse Headache
      Conditions: Medication Overuse Headache
    • NCT01217970
      Completed
      Safety Interaction Trial Ibudilast and Methamphetamine
      Conditions: Methamphetamine-dependence; Substance Abuse
    • NCT01740414
      Completed
      Effects of Ibudilast on Oxycodone Self-administration in Opioid Abusers
      Conditions: Opioid Abuse; Opioid Dependence
    • NCT01860807
      Completed
      Trial of Ibudilast for Methamphetamine Dependence
      Conditions: Methamphetamine Dependence; HIV Infection
    • NCT03489850
      Completed
      Ibudilast and Withdrawal-Related Dysphoria
      Conditions: Alcohol Use Disorder
    • NCT03533387
      Completed
      Study of MN-166 (Ibudilast) Extended Release Tablet Formulations Compared With Capsules in Healthy Volunteers
      Conditions: Healthy Volunteers
    • NCT02238626
      Completed
      Ibudilast (MN-166) in Subjects With Amyotrophic Lateral Sclerosis (ALS)
      Conditions: Amyotrophic Lateral Sclerosis
    • NCT04631471
      Not yet recruiting
      Regeneration in Cervical Degenerative Myelopathy
      Conditions: Myelopathy; Spinal Cord Diseases
    • NCT00723177
      Completed
      Phase IIa Study of AV411, a Glial Activation Inhibitor, for Opioid Withdrawal
      Conditions: Opioid-Related Disorders
      Medical Conditions
      Sponsors and Collaborators
      Drug Interventions
      Conditions
      Rare Diseases
      Drug Interventions
      Dietary Supplements
      Sponsor/Collaborators
      Locations